fluorodeoxyglucose f18 has been researched along with Lymphoma, B-Cell, Marginal Zone in 74 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (2.70) | 18.2507 |
2000's | 22 (29.73) | 29.6817 |
2010's | 39 (52.70) | 24.3611 |
2020's | 11 (14.86) | 2.80 |
Authors | Studies |
---|---|
Chen, H; Meng, T; Pang, Y; Shang, Q; Zhao, L | 1 |
Deng, Y; He, L; Xie, H; Zhang, W | 1 |
Alderuccio, JP; Cerhan, JR; Chapman, JR; Chihara, D; Cohen, JB; Flowers, CR; Friedberg, JW; Habermann, TM; Haddadi, S; Kahl, BS; Koff, JL; Larson, MC; Lossos, IS; Martin, P; Reis, IM; Strouse, C; Zhao, W | 1 |
Arends, S; Bootsma, H; Glaudemans, AWJM; Kroese, FGM; Nijland, M; Spijkervet, FKL; van der Vegt, B; van Ginkel, MS; Vissink, A | 1 |
Barbuto, L; Blasio, R; Di Serafino, M; Iacobellis, F; Pezzullo, F; Romano, L | 1 |
Igarashi, T; Ikeda, T; Tsujisaki, M; Yawata, A; Yokoyama, Y | 1 |
Avigdor, A; Ben-Haim, S; Benjamini, O; Chikman, B; Davidson, T; Goshen, E; Nissan, E; Nissan, J; Oksman, Y; Zlotnick, M | 1 |
Su, M; Wang, R | 1 |
Do, YR; Kim, DS; Kim, JS; Kim, SJ; Koh, Y; Lee, HS; Lee, WS; Moon, JH; Oh, SY; Park, Y; Shin, HJ; Song, GY; Yang, DH; Yhim, HY; Yoon, SE | 1 |
Kang, L; Su, T; Wang, H; Wang, S; Yang, L | 1 |
Choi, JY; Hyun, SH; Kim, SJ; Kim, WS; Lee, JH; Lee, KH; Min, BH; Moon, SH; Park, YJ | 1 |
Rossetti-Chung, A; Sood, S; Terezakis, S; Zhang, S | 1 |
Cheng, Z; Kou, Y; Yao, Z | 1 |
Annunziata, S; Caldarella, C; Cuccaro, A; Hohaus, S | 1 |
Albano, D; Bertagna, F; Giubbini, R | 2 |
Anas, JM; Bao, C; Chen, D; Lin, L; Liu, K; Qian, W; Wei, J; Zhao, K; Zhao, X | 1 |
Chau, K; Huang, MY; Noy, A; Qi, S; Schöder, H; Teckie, S; Yahalom, J; Yang, Y | 1 |
Cui, Z; Dong, C; Han, Y; Huang, L; Li, J; Liu, J; Ren, Y | 1 |
Nakamoto, R; Okuyama, C; Utsumi, T; Yamamoto, Y | 1 |
Chen, W; Dilsizian, V; Rezaee, A; Zhao, XF | 1 |
Fukushima, Y; Igarashi, T; Shimizu, A; Takahashi, H; Yamaguchi, H | 1 |
Adler, M; Aegerter, JP; Besson, FL; Christinat, A; de Leval, L; Frossard, V; Nguyen, C; Pomoni, A; Prior, JO; Sallak, A | 1 |
Basturk, A; Kilicarslan, A; Ozdemir, E; Turkolmez, S; Yildirim-Poyraz, N | 1 |
Cavalli, F; Ceriani, L; Giovanella, L; Sadeghi, R; Treglia, G; Zucca, E | 1 |
Ahn, BC; Jeong, JY; Kim, DH; Lee, J; Lee, SW | 1 |
Acevedo Báñez, I; Borrego-Dorado, I; Calderón-Cabrera, C; Carrillo-Cruz, E; de la Cruz Vicente, F; Espigado Tocino, I; Fernández López, R; Marín-Oyaga, VA; Pérez Vega, H; Pérez-Simón, JA; Ruiz Mercado, M; Solé Rodríguez, M; Vázquez-Albertino, R | 1 |
Choi, KD; Huh, J; Jung, HY; Kim, DH; Kim, HO; Lee, DY; Lee, JJ; Park, SH; Ryu, JS; Suh, C | 1 |
Dolak, W; Giraudo, C; Hacker, M; Hartenbach, M; Herold, CJ; Kiesewetter, B; Lukas, J; Mayerhoefer, ME; Müllauer, L; Pones, M; Raderer, M; Rausch, I; Senn, D; Simonitsch-Klupp, I; Weber, M | 1 |
Dong, A; Xiao, Z; Yang, J; Zuo, C | 1 |
Hwang, JW; Jee, SR; Kim, JH; Lee, SH; Lee, SM; Seol, SY | 1 |
Byun, BH; Choi, CW; Hwang, JP; Kim, BI; Lim, I; Lim, SM | 1 |
Albano, D; Bertagna, F; Bertoli, M; Fallanca, F; Ferro, P; Gianolli, L; Giubbini, R; Picchio, M | 1 |
Dolak, W; Karanikas, G; Kiesewetter, B; Kletter, K; Lukas, J; Mayerhoefer, ME; Müllauer, L; Pones, M; Raderer, M; Rausch, I; Simonitsch-Klupp, I; Weber, M | 1 |
Albano, D; Bertagna, F; Bosio, G; Orlando, E | 1 |
Kong, L; Shi, F; Zhang, NS; Zhu, H | 1 |
Igawa, T; Nasu, A; Sato, H; Sato, Y; Yanai, H; Yoshino, T | 1 |
Enomoto, K; Hamada, K; Hatazawa, J; Higuchi, I; Inohara, H; Kubo, T; Tomita, Y | 1 |
Hsu, CH; Lee, CJ; Lin, SE; Tai, CJ | 1 |
Kawabe, T; Mineura, K; Miyamoto, J; Owada, K; Sasajima, H; Tatsuzawa, K | 1 |
Choi, JY; Kim, BT; Kim, SJ; Kim, WS; Ko, YH; Yi, JH | 1 |
Hiyama, A; Matsunaga, N; Suga, K; Takeda, K; Yasuhiko, K | 1 |
Bonnichon-Py, A; Crémades, S; Le Floch, H; Mairovitz, A; Margery, J; Marotel, C; Rivière, F; Saint-Blancard, P; Staub, E; Vaylet, F | 1 |
Hata, M; Inayama, Y; Inoue, T; Kubota, Y; Minamimoto, R; Omura-Minamisawa, M; Tateishi, U; Tayama, Y; Tomita, N | 1 |
Agrawal, A; Agrawal, R | 1 |
Hornick, JL; Jagannathan, JP; LaCasce, AS; O'Regan, K; Ramaiya, NH; Shinagare, AB | 1 |
Friedman, K; Mayo, J; Moskovits, T; Probst, S | 1 |
Bilici, A; Canpolat, N; Gumus, M; Salepci, T; Seker, M; Ustaalioglu, BB | 1 |
Kurita, A; Okazaki, M; Sawada, S; Shien, K; Suehisa, H; Yamashita, M | 1 |
Ichikawa, K; Komatsu, N; Sato, E; Sugimoto, K; Sunami, Y; Ushimi, T; Watanabe, N | 1 |
Ichimura, K; Matsuo, T; Yoshino, T | 1 |
Arikawa, S; Hayabuchi, N; Hirose, Y; Ishibashi, M; Kaida, H; Kurata, S; Nakahara, K; Ohshima, K; Uozumi, J | 1 |
Ichimura, K; Kaji, M; Matsuo, T; Tanaka, T | 1 |
Asselain, B; Bénamor, M; Decaudin, D; Dendale, R; Moulin-Romsee, G; Plancher, C; Rouic, LL; Sahli, R; Servois, V; Validire, P; Vincent-Salomon, A; Zanni, M | 1 |
Dai, BL; Ling, L; Luo, XM; Luo, YZ; Wang, QY; Yan, SX; Zhao, K; Zhou, SH | 1 |
Campeau, RJ; David, O; Dowling, AM | 1 |
Gallowitsch, HJ; Kresnik, E; Lind, P; Mikosch, P; Würtz, FG | 1 |
Becherer, A; Chott, A; Hoffmann, M; Jäger, U; Kletter, K; Raderer, M | 1 |
Beal, KP; Yahalom, J; Yeung, HW | 1 |
Chott, A; Hoffmann, M; Raderer, M; Streubel, B; Woehrer, S | 1 |
López-López, R; Luna-Vega, V; Punal-Vidal, L; Ruibal-Morell, A; Sánchez-Salmon, A | 1 |
Al-Nahhas, A; Alavi, A; Ambrosini, V; Castellucci, P; Fanti, S; Farsad, M; Nanni, C; Rubello, D; Tehranipour, N; Zinzani, P | 1 |
Finger, PT; Iacob, CE; Kurli, M; Roe, RH; Tena, LB | 1 |
Chang, CC; Hsu, CH; Lin, YH; Liu, JD; Tai, CJ | 1 |
Becherer, A; Chott, A; Hoffmann, M; Kletter, K; Raderer, M; Streubel, B; Wöhrer, S | 1 |
Alinari, L; Ambrosini, V; Berkowitz, A; Castellucci, P; Elstrom, R; Fanti, S; Farsad, M; Franchi, R; Nanni, C; Stefoni, V; Tani, M; Zinzani, PL | 1 |
Hicks, RJ; Lau, E; Mac Manus, MP; Ryan, G; Wirth, A | 1 |
Li, S; Mauch, PM; Ng, AK; Silver, B; Stevenson, MA; Tsai, HK | 1 |
Bairey, O; Herishanu, Y; Metzer, U; Naparstek, E; Perry, C; Polliack, A; Ruchlemer, R; Sapir, EE; Trejo, L | 1 |
Bae, YA; Chung, MJ; Han, J; Kim, BT; Kim, TS; Ko, YH; Lee, KS | 1 |
Rodriguez, M | 1 |
Becherer, A; Chott, A; Diemling, M; Hoffmann, M; Kletter, K; Petkov, V; Pfeffel, F; Raderer, M | 1 |
Aigner, RM; Karpf, E; Schwarz, T; Wurzinger, G | 1 |
Hara, M; Iida, A; Kiriyama, M; Okano, M; Satake, M; Sugie, C; Tateyama, H; Tohyama, J | 1 |
4 review(s) available for fluorodeoxyglucose f18 and Lymphoma, B-Cell, Marginal Zone
Article | Year |
---|---|
Diffuse large B cell lymphoma in a preceding IgG4-related disease with kidney restricted lambda light chain expression: case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunoglobulin G4-Related Disease; Immunoglobulin lambda-Chains; Immunosuppressive Agents; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Missed Diagnosis; Nephritis, Interstitial; Positron Emission Tomography Computed Tomography; Prednisone; Radiopharmaceuticals; Renal Insufficiency, Chronic | 2020 |
Prognostic value of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in primary hepatic mucosa-associated lymphoid tissue lymphoma: A case report and review of the literature.
Topics: Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2018 |
Detection rate of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with marginal zone lymphoma of MALT type: a meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2015 |
18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in mucosa-associated lymphoid tissue lymphoma of the larynx: a case report and literature review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Laryngeal Neoplasms; Lymphoma, B-Cell, Marginal Zone; Prednisone; Radionuclide Imaging; Treatment Outcome; Vincristine | 2012 |
1 trial(s) available for fluorodeoxyglucose f18 and Lymphoma, B-Cell, Marginal Zone
Article | Year |
---|---|
Usefulness and limitations of fluorine-18-fluorodeoxyglucose positron emission tomography for the detection of malignancy of orbital tumors.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Astrocytoma; Carcinoma, Adenoid Cystic; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Hemangioma, Cavernous, Central Nervous System; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Melanoma; Middle Aged; Neurilemmoma; Optic Nerve Neoplasms; Orbital Neoplasms; Orbital Pseudotumor; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2008 |
69 other study(ies) available for fluorodeoxyglucose f18 and Lymphoma, B-Cell, Marginal Zone
Article | Year |
---|---|
18F-FDG Versus 68Ga-FAPI PET/CT in Visualizing Primary Hepatic Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoid Tissue; Lymphoma, B-Cell, Marginal Zone; Male; Positron Emission Tomography Computed Tomography; Quinolines | 2022 |
18F-FDG PET/CT Findings of MALT Lymphoma of Ureter.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Ureter | 2022 |
Predictive value of staging PET/CT to detect bone marrow involvement and early outcomes in marginal zone lymphoma.
Topics: Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2023 |
FDG-PET/CT discriminates between patients with and without lymphomas in primary Sjögren's syndrome.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sjogren's Syndrome | 2023 |
Secondary Neurolymphomatosis of the Radial Nerve: A Diagnostic Challenge.
Topics: Biopsy; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Magnetic Resonance Imaging; Male; Middle Aged; Neurolymphomatosis; Peripheral Nervous System Neoplasms; Positron Emission Tomography Computed Tomography; Radial Neuropathy; Ultrasonography | 2019 |
[Primary biliary cholangitis complicated by primary hepatic extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue].
Topics: Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Liver Cirrhosis, Biliary; Lymphoid Tissue; Lymphoma, B-Cell, Marginal Zone; Neoplasm Recurrence, Local | 2019 |
PET/CT in Disease Detection and Follow-up of Subcutaneous Involvement in Marginal Zone Lymphoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2020 |
Pulmonary mucosa-associated lymphoid tissue lymphoma with internal calcifications on positron-emission tomography/CT.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lymphoma, B-Cell, Marginal Zone; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Retrospective Studies; Rituximab; Survival Analysis; Vincristine | 2020 |
Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformation.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Survival Rate; Young Adult | 2021 |
The use of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography integrated with computed tomography for accurate staging and surveillance in the case of mucosa-associated lymphoid tissue.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoid Tissue; Lymphoma, B-Cell, Marginal Zone; Male; Mucous Membrane; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Watchful Waiting | 2021 |
Hepatic Lesion of Mucosa-Associated Lymphoid Tissue Lymphoma Revealed by Al18F-NOTA-FAPI-04 PET/CT.
Topics: Fluorodeoxyglucose F18; Heterocyclic Compounds, 1-Ring; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Quinolines | 2022 |
Dural MALT Lymphoma Detected by 11C-Methionine PET/CT.
Topics: Biological Transport; Carbon Radioisotopes; Dura Mater; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Methionine; Middle Aged; Positron Emission Tomography Computed Tomography | 2017 |
18F-FDG PET/CT in splenic marginal zone lymphoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Spleen; Splenic Neoplasms | 2018 |
Uptake of [
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Young Adult | 2018 |
18F-FDG PET/CT for staging and response assessment of primary parotid MALT lymphoma with multiple sites involvement: A case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Neoplasm Staging; Parotid Neoplasms; Positron Emission Tomography Computed Tomography; Prednisone; Rituximab; Vincristine | 2019 |
Splenic Marginal Zone B-Cell Lymphoma With Splenic Infarction in a Patient With Cold Agglutinin Disease.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Splenic Infarction; Splenic Neoplasms | 2019 |
Pediatric presentation of splenic marginal zone lymphoma on FDG PET/CT scan.
Topics: Child, Preschool; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Multimodal Imaging; Positron-Emission Tomography; Splenic Neoplasms; Tomography, X-Ray Computed | 2014 |
A definitive diagnosis of mucosa-associated lymphoid tissue lymphoma made at a second biopsy.
Topics: Adult; Biopsy; Cell Differentiation; Conjunctiva; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Conjunctival MALT lymphoma: utility of FDG PET/CT for diagnosis, staging, and evaluation of treatment response.
Topics: Aged; Conjunctiva; Conjunctival Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging | 2014 |
PET/CT findings in a case with FDG-avid disseminated lacrimal gland MALToma with sequential development of large B-cell lymphoma and gastric MALToma.
Topics: Aged; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lacrimal Apparatus Diseases; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
18F-FDG PET/CT finding of bilateral primary breast mucosa-associated lymphoid tissue lymphoma.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Role of 18F-FDG-PET/CT in the management of marginal zone B cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
18F-Fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography in mucosa-associated lymphoid tissue lymphoma: variation in 18F-FDG avidity according to site involvement.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Endoscopy; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2015 |
Does Delayed-Time-Point Imaging Improve 18F-FDG-PET in Patients With MALT Lymphoma?: Observations in a Series of 13 Patients.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
CT, MRI, and 18F-FDG PET/CT Findings in Untreated Pulmonary and Hepatic B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Over a Five-Year Period: A Case Report.
Topics: Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed | 2016 |
Efficacy of Positron Emission Tomography/Computed Tomography in Gastric Mucosa-associated Lymphoid Tissue Lymphoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Gastroscopy; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Stomach Neoplasms | 2016 |
18F-FDG PET/CT and primary hepatic MALT: a case series.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2016 |
Prognostic value of SUVmax measured by pretreatment 18F-FDG PET/CT in patients with primary gastric lymphoma.
Topics: Adult; Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Kaplan-Meier Estimate; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms | 2016 |
18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2017 |
Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Immunotherapy; Lacrimal Apparatus Diseases; Lung Neoplasms; Lymph Nodes; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Multidetector Computed Tomography; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Remission Induction; Rituximab; Soft Tissue Neoplasms; Splenic Neoplasms; Stomach Neoplasms; Treatment Outcome | 2016 |
Role of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in evaluating breast mucosa-associated lymphoid tissue lymphoma: A case series.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Positron Emission Tomography Computed Tomography | 2017 |
Mucosa-associated lymphoid tissue lymphoma with unusual
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Colectomy; Colon, Sigmoid; Colonoscopy; Colorectal Neoplasms; Cyclophosphamide; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prednisone; Remission Induction; Rituximab; Sigmoid Neoplasms; Vincristine | 2017 |
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue with plasma cell differentiation: Periodic acid-schiff reaction-positive Dutcher body is a diagnostic clue to distinguish it from plasmacytoma.
Topics: Aged, 80 and over; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoid Tissue; Lymphoma, B-Cell, Marginal Zone; Male; Parotid Gland; Plasmacytoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Mucosa-associated lymphoid tissue lymphoma studied with FDG-PET: a comparison with CT and endoscopic findings.
Topics: Adult; Aged; Endoscopy; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2008 |
FDG-PET for a thyroid MALT lymphoma.
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2008 |
18F-FDG uptake and its clinical relevance in primary gastric lymphoma.
Topics: Adult; Aged; Biopsy; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastric Mucosa; Gastroscopy; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Stomach Neoplasms; Stomach Ulcer; Tomography, X-Ray Computed; Young Adult | 2010 |
F-18 FDG PET/CT findings in a patient with bilateral orbital and gastric mucosa-associated lymphoid tissue lymphomas.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Neoplasm Staging; Orbital Neoplasms; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2009 |
[Acute dyspnoea and rare endobronchial tumour].
Topics: Acute Disease; Aged, 80 and over; Airway Obstruction; Bronchial Neoplasms; Bronchoscopy; Dyspnea; Echocardiography; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
F-18 FDG PET/CT evaluation of radiotherapy response in rare case of mucosa-associated lymphoid tissue lymphoma.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Positron-Emission Tomography; Rare Diseases; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Imaging features in a rare case of MALTOMA of the thyroid.
Topics: Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Ultrasonography | 2010 |
Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma.
Topics: Biopsy; Diagnosis, Differential; Endoscopy, Gastrointestinal; Female; Fluorodeoxyglucose F18; Helicobacter pylori; Humans; Immunohistochemistry; Lymphoma, B-Cell, Marginal Zone; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2011 |
The appearance of epidural extranodal marginal zone lymphoma (MALToma) on F-18 FDG PET/CT and post hoc PET/MRI fusion.
Topics: Adult; Epidural Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma, B-Cell, Marginal Zone; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Pulmonary BALT lymphoma successfully treated with eight cycles weekly rituximab: report of first case and F-18 FDG PET/CT images.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Positron-Emission Tomography; Radiopharmaceuticals; Rituximab; Tomography, X-Ray Computed | 2011 |
Pulmonary mucosa-associated lymphoid tissue lymphoma with a pulmonary arteriovenous fistula.
Topics: Arteriovenous Fistula; Biopsy, Needle; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Pneumonectomy; Positron-Emission Tomography; Pulmonary Artery; Pulmonary Veins; Radiopharmaceuticals; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
18F-Fluorodeoxyglucose positron emission tomography/computed tomography revealed the presence of simultaneous colon cancer in mucosa-associated lymphoid tissue lymphoma.
Topics: Aged; Blotting, Southern; Colonic Neoplasms; Colonoscopy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; In Situ Hybridization, Fluorescence; Lymphoma, B-Cell, Marginal Zone; Mouth Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Local recurrence as immunoglobulin G4 (IgG4)-related disease 10 years after radiotherapy to ocular adnexal extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.
Topics: B-Lymphocytes; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Immunohistochemistry; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Orbital Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Comparison between endoscopic macroscopic classification and F-18 FDG PET findings in gastric mucosa-associated lymphoid tissue lymphoma patients.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Endoscopy; Female; Fluorodeoxyglucose F18; Gastric Mucosa; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Positron-Emission Tomography; Young Adult | 2012 |
Conjunctival lymphoma can be detected by FDG PET.
Topics: Aged; Conjunctival Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Value of 18FDG PET scan in staging of ocular adnexal lymphomas: a large single-center experience.
Topics: Aged; Conjunctiva; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lacrimal Apparatus; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Orbit; Positron-Emission Tomography; Radioisotopes; Retrospective Studies | 2012 |
Pituitary adenoma detected on FDG positron emission tomography in a patient with mucosa-associated lymphoid tissue lymphoma.
Topics: Adenoma; Brain; Diagnosis, Differential; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Pituitary Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Whole-Body Counting | 2003 |
F-18-FDG-PET in a patient with Hashimoto's thyroiditis and MALT lymphoma recurrence of the thyroid.
Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule; Thyroidectomy; Thyroiditis, Autoimmune; Tomography, Emission-Computed | 2003 |
18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2003 |
FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases.
Topics: Adult; Aged; Aged, 80 and over; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2005 |
Transformation of MALT lymphoma to pure plasma cell histology following treatment with the anti-CD20 antibody rituximab.
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cell Differentiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Male; Plasma Cells; Rituximab; Stomach Neoplasms; Treatment Outcome | 2005 |
A case of orbital malt lymphoma with breast involvement detected by 18FDG-positron emission tomography.
Topics: Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Orbital Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Diagnostic role of 18F-FDG PET in gastric MALT lymphoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Remission Induction; Retrospective Studies; Stomach Neoplasms; Time Factors | 2006 |
Whole-body positron emission tomography/computed tomography imaging and staging of orbital lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Neoplasm Staging; Orbital Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, High-Energy; Retrospective Studies; Tomography, X-Ray Computed; Whole Body Imaging | 2006 |
FDG-PET in a patient with gastric MALT lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Stomach Neoplasms; Taiwan | 2006 |
18F-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Positron-Emission Tomography; Translocation, Genetic | 2006 |
18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2006 |
Positron emission tomography of stage IV mucosa-associated lymphoid tissue lymphoma confined to the four major salivary glands.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Salivary Gland Neoplasms | 2007 |
Role of radiation therapy in the treatment of stage I/II mucosa-associated lymphoid tissue lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Retrospective Studies | 2007 |
Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Data Collection; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed | 2007 |
Marginal zone B-cell lymphoma of bronchus-associated lymphoid tissue: imaging findings in 21 patients.
Topics: Adult; Aged; Bronchi; Bronchography; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Computed tomography, magnetic resonance imaging and positron emission tomography in non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Forecasting; Gastroscopy; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Methionine; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Radiopharmaceuticals; Remission Induction; Stomach Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Prospective Studies; Tomography, Emission-Computed | 1999 |
Detection of unsuspected gastric MALT-lymphoma with F-18-FDG-PET.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Male; Neoplasms, Second Primary; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed | 2000 |
Increased (18)fluorodeoxyglucose accumulation in mucosa-associated lymphoid tissue-type lymphoma of the lung.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |